These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
408 related articles for article (PubMed ID: 24100253)
1. Beneficial effects of pioglitazone on atrial structural and electrical remodeling in vitro cellular models. Gu J; Liu X; Wang QX; Guo M; Liu F; Song ZP; Zhang DD J Mol Cell Cardiol; 2013 Dec; 65():1-8. PubMed ID: 24100253 [TBL] [Abstract][Full Text] [Related]
2. Angiotensin II increases CTGF expression via MAPKs/TGF-β1/TRAF6 pathway in atrial fibroblasts. Gu J; Liu X; Wang QX; Tan HW; Guo M; Jiang WF; Zhou L Exp Cell Res; 2012 Oct; 318(16):2105-15. PubMed ID: 22749815 [TBL] [Abstract][Full Text] [Related]
3. Pioglitazone inhibits angiotensin II-induced atrial fibroblasts proliferation via NF-κB/TGF-β1/TRIF/TRAF6 pathway. Chen XQ; Liu X; Wang QX; Zhang MJ; Guo M; Liu F; Jiang WF; Zhou L Exp Cell Res; 2015 Jan; 330(1):43-55. PubMed ID: 25152439 [TBL] [Abstract][Full Text] [Related]
4. Pioglitazone improves potassium channel remodeling induced by angiotensin II in atrial myocytes. Gu J; Hu W; Liu X Med Sci Monit Basic Res; 2014 Oct; 20():153-60. PubMed ID: 25296378 [TBL] [Abstract][Full Text] [Related]
6. Troglitazone suppresses transforming growth factor-beta1-induced collagen type I expression in keloid fibroblasts. Zhang GY; Yi CG; Li X; Ma B; Li ZJ; Chen XL; Guo SZ; Gao WY Br J Dermatol; 2009 Apr; 160(4):762-70. PubMed ID: 19120328 [TBL] [Abstract][Full Text] [Related]
7. Pioglitazone attenuates atrial remodeling and vulnerability to atrial fibrillation in alloxan-induced diabetic rabbits. Liu C; Liu R; Fu H; Li J; Wang X; Cheng L; Korantzopoulos P; Tse G; Li G; Liu T Cardiovasc Ther; 2017 Oct; 35(5):. PubMed ID: 28665544 [TBL] [Abstract][Full Text] [Related]
8. Role of leptin signaling in the pathogenesis of angiotensin II-mediated atrial fibrosis and fibrillation. Fukui A; Takahashi N; Nakada C; Masaki T; Kume O; Shinohara T; Teshima Y; Hara M; Saikawa T Circ Arrhythm Electrophysiol; 2013 Apr; 6(2):402-9. PubMed ID: 23406575 [TBL] [Abstract][Full Text] [Related]
9. Angiotensin II increases periostin expression via Ras/p38 MAPK/CREB and ERK1/2/TGF-β1 pathways in cardiac fibroblasts. Li L; Fan D; Wang C; Wang JY; Cui XB; Wu D; Zhou Y; Wu LL Cardiovasc Res; 2011 Jul; 91(1):80-9. PubMed ID: 21367774 [TBL] [Abstract][Full Text] [Related]
10. Role of the MAPKs/TGF-β1/TRAF6 signaling pathway in atrial fibrosis of patients with chronic atrial fibrillation and rheumatic mitral valve disease. Zhang D; Liu X; Chen X; Gu J; Li F; Zhang W; Zheng Y Cardiology; 2014; 129(4):216-23. PubMed ID: 25376239 [TBL] [Abstract][Full Text] [Related]
11. PPAR-γ activation by rosiglitazone suppresses angiotensin II-mediated proliferation and phenotypictransition in cardiac fibroblasts via inhibition of activation of activator protein 1. Hou X; Zhang Y; Shen YH; Liu T; Song S; Cui L; Bu P Eur J Pharmacol; 2013 Sep; 715(1-3):196-203. PubMed ID: 23791613 [TBL] [Abstract][Full Text] [Related]
12. Pioglitazone induces apoptosis in human vascular smooth muscle cells from diabetic patients involving the transforming growth factor-beta/activin receptor-like kinase-4/5/7/Smad2 signaling pathway. Ruiz E; Redondo S; Gordillo-Moscoso A; Tejerina T J Pharmacol Exp Ther; 2007 May; 321(2):431-8. PubMed ID: 17267584 [TBL] [Abstract][Full Text] [Related]
13. TGF-β1 downregulates AT1 receptor expression via PKC-δ-mediated Sp1 dissociation from KLF4 and Smad-mediated PPAR-γ association with KLF4. Zhang XH; Zheng B; Gu C; Fu JR; Wen JK Arterioscler Thromb Vasc Biol; 2012 Apr; 32(4):1015-23. PubMed ID: 22282354 [TBL] [Abstract][Full Text] [Related]
14. Angiotensin II increases collagen I expression via transforming growth factor-beta1 and extracellular signal-regulated kinase in cardiac fibroblasts. Gao X; He X; Luo B; Peng L; Lin J; Zuo Z Eur J Pharmacol; 2009 Mar; 606(1-3):115-20. PubMed ID: 19374881 [TBL] [Abstract][Full Text] [Related]
15. Peroxisome proliferator-activated receptor-gamma (PPAR-gamma) agonist inhibits transforming growth factor-beta1 and matrix production in human dermal fibroblasts. Zhang GY; Cheng T; Zheng MH; Yi CG; Pan H; Li ZJ; Chen XL; Yu Q; Jiang LF; Zhou FY; Li XY; Yang JQ; Chu TG; Gao WY J Plast Reconstr Aesthet Surg; 2010 Jul; 63(7):1209-16. PubMed ID: 19617014 [TBL] [Abstract][Full Text] [Related]
16. MFGE8 attenuates Ang-II-induced atrial fibrosis and vulnerability to atrial fibrillation through inhibition of TGF-β1/Smad2/3 pathway. Ge Z; Chen Y; Wang B; Zhang X; Yan Y; Zhou L; Zhang Y; Xie Y J Mol Cell Cardiol; 2020 Feb; 139():164-175. PubMed ID: 31958465 [TBL] [Abstract][Full Text] [Related]
17. Pioglitazone inhibits cell growth and reduces matrix production in human kidney fibroblasts. Zafiriou S; Stanners SR; Saad S; Polhill TS; Poronnik P; Pollock CA J Am Soc Nephrol; 2005 Mar; 16(3):638-45. PubMed ID: 15689403 [TBL] [Abstract][Full Text] [Related]
18. Activation of peroxisome proliferator-activated receptor-gamma inhibits transforming growth factor-beta1 induction of connective tissue growth factor and extracellular matrix in hypertrophic scar fibroblasts in vitro. Zhang GY; Cheng T; Zheng MH; Yi CG; Pan H; Li ZJ; Chen XL; Yu Q; Jiang LF; Zhou FY; Li XY; Yang JQ; Chu TG; Gao WY Arch Dermatol Res; 2009 Aug; 301(7):515-22. PubMed ID: 19466435 [TBL] [Abstract][Full Text] [Related]
19. The Role of the Rho/ROCK Pathway in Ang II and TGF-β1-Induced Atrial Remodeling. Liu LJ; Yao FJ; Lu GH; Xu CG; Xu Z; Tang K; Cheng YJ; Gao XR; Wu SH PLoS One; 2016; 11(9):e0161625. PubMed ID: 27611832 [TBL] [Abstract][Full Text] [Related]
20. PPAR-γ activator pioglitazone prevents age-related atrial fibrillation susceptibility by improving antioxidant capacity and reducing apoptosis in a rat model. Xu D; Murakoshi N; Igarashi M; Hirayama A; Ito Y; Seo Y; Tada H; Aonuma K J Cardiovasc Electrophysiol; 2012 Feb; 23(2):209-17. PubMed ID: 21954843 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]